Skip to main content
. 2010 Jan 27;16(3):839–849. doi: 10.1089/ten.tea.2009.0113

FIG. 5.

FIG. 5.

CD31 immunofluorescent staining. (A) Comparison of the average number of CD31+ cells/high-powered field between the experimental groups. §Significantly different when compared with C + PBS at 5 weeks (p = 0.00). ΦSignificantly different when compared with C + MDSC + TM at 1 week (p = 0.03). (B) Immunofluorescence of CD31 (red) after 1- and 5-week treatment (20 × objective).